石榴汁和菜提取物的饮料组合改善了大鼠研究中的脂质特征
Kavyashree K N1, Bhuvaneshwari G2, Ganiger V M3
1Department of Post Harvest Management, College of Horticulture, Bagalkot, Karnataka, India.
Plant foods for human nutrition (Dordrecht, Netherlands)
|December 19, 2024
概括
这项研究表明,石榴和菜饮料显著改善了肥胖大鼠的脂质样本. 功能饮料降低了胆固醇和甘油三,同时增加了高密度脂蛋白 (HDL) 水平.
科学领域:
- 营养科学 营养科学
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 关于水果和谷物谷物饮料对脂质谱的影响的研究有限.
- 石榴和昆富含有促进健康的多.
研究的目的:
- 为了研究石榴汁和奎诺亚种子提取物饮料对肥胖大鼠的脂质资料的影响.
- 评估这种饮料作为功能性食品的潜力.
主要方法:
- 肥胖的老鼠被口服了一种含有80%石榴汁和20%菜提取物的饮料.
- 测量了血清脂质水平,包括甘油三,总胆固醇,高密度胆固醇,低密度胆固醇和低密度胆固醇.
主要成果:
- 这种饮料显著降低了血清甘油三 (16.51-17.02%) 和总胆固醇 (18.65-19.54%).
- 黄 LDL 和 LDL 的水平分别下降了 12.93-14.69% 和 13.66-14.64%.
- 在接受治疗的肥胖大鼠中,HDL胆固醇增加了18-20%.
结论:
- 配制的石榴和菜饮料对肥胖大鼠的脂质资料产生了显著的有益影响.
- 这种饮料可以被认为是一个有前途的功能性食品,用于管理失脂症.
更多相关视频
13:09Rapid Model to Evaluate the Anti-Obesity Potential of a Combination of Syzygium aromaticum Clove and Cuminun cyminum Cumin on C57BL6/j Mice Fed High-Fat Diet
Published on: July 31, 2021
3.7K
11:06Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
Published on: April 7, 2023
1.9K
相关概念视频
Lipid Digestion
73.0K
Lipids are large molecules that are generally not water-soluble. Since most of the digestive enzymes in the human body are water-based, there are specific steps the body must take to break down lipids and make them available for use.
73.0K
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.7K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.7K
Atherosclerosis III: Management
726
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
726
